Page last updated: 2024-11-05

trihexyphenidyl and Anton Syndrome

trihexyphenidyl has been researched along with Anton Syndrome in 1 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Research Excerpts

ExcerptRelevanceReference
"Transient, postictal cortical blindness is a rare adverse effect of electroconvulsive therapy (ECT)."1.38Continuation of ECT after recovery from transient, ECT-induced, postictal cortical blindness. ( Andrade, C; Bambole, V; Bang, A; Shah, N; Sonavane, S, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sonavane, S1
Bambole, V1
Bang, A1
Shah, N1
Andrade, C1

Other Studies

1 other study available for trihexyphenidyl and Anton Syndrome

ArticleYear
Continuation of ECT after recovery from transient, ECT-induced, postictal cortical blindness.
    The journal of ECT, 2012, Volume: 28, Issue:1

    Topics: Adolescent; Anti-Dyskinesia Agents; Antipsychotic Agents; Atropine; Benzodiazepines; Blindness, Cort

2012